Celldex's market cap is currently $1.71B. The company's EPS TTM is $-1.01; its P/E ratio is -7.48; Celldex is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-1.00. See an overview of income statement, balance sheet, and cash flow financials.
